脑微出血机制与危险因素的研究进展

doi:10.3969/j.issn.1004-583X.2021.08.015

摘要/Abstract

摘要：

脑微出血(cerebral microbleeds, CMBs)增加了卒中、认知障碍等相关疾病的风险。现就CMBs的流行病学现状、影像学特点、危险因素、发病机制等方面进行综述,为CMBs的深入探究及科学防治提供依据。

中图分类号:

R743

王慧玲, 郑连红, 王萌. 脑微出血机制与危险因素的研究进展[J]. 临床荟萃, 2021, 36(8): 749-752.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://lchc.magtechjournal.com/CN/10.3969/j.issn.1004-583X.2021.08.015

https://lchc.magtechjournal.com/CN/Y2021/V36/I8/749

参考文献 32

[1]	Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: A clinical review[J]. Neurology, 2019, 92(24):1146-1156. doi: 10.1212/WNL.0000000000007654 pmid: 31142635
[2]	Han F, Zhai FF, Wang Q, et al. Prevalence and risk factors of cerebral small vessel disease in a Chinese population-based sample[J]. J Stroke, 2018, 20(2):239-246. doi: 10.5853/jos.2017.02110 URL
[3]	Haji S, Planchard R, Zubair A, et al. The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation[J]. J Neurol, 2016, 263(2):238-244. doi: 10.1007/s00415-015-7966-2 URL
[4]	De Guio F, Jouvent E, Biessels GJ, et al. Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease[J]. J Cereb Blood Flow Metab, 2016, 36:1319-1337. doi: 10.1177/0271678X16647396 URL
[5]	Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: A guide to detection and interpretation[J]. Lancet Neurol, 2009, 8(2):165-174. doi: 10.1016/S1474-4422(09)70013-4 pmid: 19161908
[6]	Kikuno M, Ueno Y, Shimizu T, et al. Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke[J]. J Neurol, 2020, 267(5):1482-1490. doi: 10.1007/s00415-020-09732-4 URL
[7]	李永琴, 陈飞, 张微微, 等. 脑微出血及其分布与肾功能的相关性分析[J]. 中华老年心脑血管病杂志, 2019, 21(9):926-929.
[8]	Patwa J, Flora SJS. Heavy metal-induced cerebral small vessel disease: Insights into molecular mechanisms and possible reversal strategies[J]. Int J Mol Sci, 2020, 21(11):3862. doi: 10.3390/ijms21113862 URL
[9]	Iadecola C, Parikh NS. Blood pressure ups and downs foreshadow cerebral microangiopathy[J]. J Am Coll Cardiol, 2020, 75(19):2400-2402.
[10]	Lyu L, Shen J, Zeng C, et al. Cerebral microbleeds are associated with blood pressure levels in individuals with hypertension[J]. Clin Exp Hypertens, 2020, 42(4):328-334. doi: 10.1080/10641963.2019.1665673 URL
[11]	Thorn LM, Shams S, Gordin D, et al. Clinical and MRI features of cerebral small-vessel disease in type 1 diabetes[J]. Diabetes Care, 2019, 42(2):327-330. doi: 10.2337/dc18-1302 pmid: 30552131
[12]	Lei C, Zhong L, Ling Y, et al. Blood glucose levels are associated with cerebral microbleeds in patients with acute ischaemic stroke[J]. Eur Neurol, 2018, 80(3/4):187-192. doi: 10.1159/000494990 URL
[13]	Patet C, Suys T, Carteron L, et al. Cerebral lactate metabolism after traumatic brain injury[J]. Curr Neurol Neurosci Rep, 2016, 16(4):31. doi: 10.1007/s11910-016-0638-5 URL
[14]	MacGregor Sharp M, Saito S, Keable A, et al. Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia[J]. Acta Neuropathol Commun, 2020, 8(1):131. doi: 10.1186/s40478-020-01009-1 URL
[15]	Zhou YN, Gao HY, Zhao FF, et al. The study on analysis of risk factors for severity of white matter lesions and its correlation with cerebral microbleeds in the elderly with lacunar infarction[J]. Medicine (Baltimore), 2020, 99(4):e18865. doi: 10.1097/MD.0000000000018865 URL
[16]	Fan D, Chaudhari NN, Rostowsky KA, et al. Post-traumatic cerebral microhemorrhages and their effects upon white matter connectivity in the aging human brain[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2019, 2019:198-203. doi: 10.1109/EMBC.2019.8857921 pmid: 31945877
[17]	Zhang H, Deng J, Sun N, et al. Effect of coagulation function on cerebral microbleeds in intracerebral hemorrhage[J]. Brain Behav, 2020, 10(6):e01634.
[18]	Elkhatib THM, Elsaid AF, Al-Molla RM, et al. Prevalence and associated risk factors of cerebral microbleeds in Egyptian patients with acute ischemic stroke and atrial fibrillation[J]. J Stroke Cerebrovasc Dis, 2020, 29(5):104703. doi: S1052-3057(20)30074-4 pmid: 32111450
[19]	Alaa El Din A, Debeaumarche H, Thouant P, et al. Cerebral microbleeds and acute myocardial infarction: Screening and disease progression[J]. Int J Cardiol Heart Vasc, 2020, 28:100531.
[20]	Parikh NS, Dueker N, Varela D, et al. Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers[J]. J Neurol Sci, 2020, 416:116981. doi: 10.1016/j.jns.2020.116981 pmid: 32592869
[21]	Silva RMFLD, Miranda CM, Liu T, et al. Atrial fibrillation and risk of dementia: Epidemiology, mechanisms, and effect of anticoagulation[J]. Front Neurosci, 2019, 13:18. doi: 10.3389/fnins.2019.00018 URL
[22]	Graff-Radford J, Lesnick T, Rabinstein AA, et al. Cerebral microbleed incidence, relationship to amyloid burden: The mayo clinic study of aging[J]. Neurology, 2020, 94(2):e190-e199. doi: 10.1212/WNL.0000000000008735 URL
[23]	Ingala S, Mazzai L, Sudre CH, et al. The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals[J]. Neurobiol Aging, 2020, 95:104-114. doi: 10.1016/j.neurobiolaging.2020.06.015 URL
[24]	Zhu Z, Jiang Y, Cui M, et al. ALDH2 rs671 polymorphisms and the risk of cerebral microbleeds in Chinese elderly: The Taizhou imaging study[J]. Ann Transl Med, 2020, 8(5):229. doi: 10.21037/atm URL
[25]	Kim SH, Shin DW, Yun JM, et al. Kidney dysfunction and cerebral microbleeds in neurologically healthy adults[J]. PLoS One, 2017, 12(2):e0172210.
[26]	Peng Q, Sun W, Liu W, et al. Longitudinal relationship between chronic kidney disease and distribution of cerebral microbleeds in patients with ischemic stroke[J]. J Neurol Sci, 2016, 362:1-6. doi: 10.1016/j.jns.2016.01.015 URL
[27]	Lau WL, Nunes ACF, Vasilevko V, et al. Chronic kidney disease increases cerebral microbleeds in mouse and man[J]. Transl Stroke Res, 2020, 11(1):122-134 doi: 10.1007/s12975-019-00698-8 URL
[28]	Phillips NS, Hillenbrand CM, Mitrea BG, et al. Cerebral microbleeds in adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation[J]. Sci Rep, 2020, 10(1):692. doi: 10.1038/s41598-020-57682-8 URL
[29]	Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: Evolution of the Boston criteria[J]. Stroke, 2018, 49:491-497. doi: 10.1161/STROKEAHA.117.016990 pmid: 29335334
[30]	Romero JR, Demissie S, Beiser A, et al. Relation of plasma β-amyloid, clusterin, and tau with cerebral microbleeds: Framingham heart study[J]. Ann Clin Transl Neurol, 2020, 7(7):1083-1091. doi: 10.1002/acn3.v7.7 URL
[31]	Van Veluw SJ, Frosch MP, Scherlek AA, et al. In vivo characterization of spontaneous microhemorrhage formation in mice with cerebral amyloid angiopathy[J]. J Cereb Blood Flow Metab, 2020, 27:271678X19899377.
[32]	Seaton A, Tran L, Chen R, et al. Pollution, particles, and dementia: A hypothetical causative pathway[J]. Int J Environ Res Public Health, 2020, 17(3):862. doi: 10.3390/ijerph17030862 URL

脑微出血机制与危险因素的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 32

相关文章 15

编辑推荐

Metrics

本文评价

[1]	许慧峰, 晋艳勇, 苟若澜, 胡明哲. 脑出血患儿并发脑积水的危险因素及预测模型[J]. 临床荟萃, 2025, 40(4): 325-328.
[2]	童明霞, 陈柯, 向小聪, 周丽峰. 中青年体检人群瘦型代谢相关脂肪性肝病及其危险因素分析[J]. 临床荟萃, 2025, 40(2): 128-132.
[3]	钱晨莹, 闫文君, 黄燕, 赵志. 肝硬化失代偿期患者合并多重耐药菌感染的危险因素分析[J]. 临床荟萃, 2025, 40(2): 143-146.
[4]	崔凯歌, 刘丽莹, 孙利强, 胡婧, 于佳琪, 贾娟, 杨冀萍. 卵圆孔未闭:基于影像学证据的相关中枢神经机制[J]. 临床荟萃, 2025, 40(2): 172-179.
[5]	蒲茜, 成刚, 道杰草, 齐梓兆, 窦乐乐, 赵军芳, 张文君, 郭彩霞, 王莹莹. 甘肃地区单中心慢性肾脏病患者便秘患病率及危险因素分析[J]. 临床荟萃, 2025, 40(1): 44-53.
[6]	赵一品, 崔清洋. 超早产儿/超低出生体重儿支气管肺发育不良危险因素分析[J]. 临床荟萃, 2025, 40(1): 60-64.
[7]	韩铠阳, 冯铜铜, 包瑛. 儿童狼疮性肾炎合并神经精神狼疮的临床特征和危险因素[J]. 临床荟萃, 2024, 39(9): 812-815.
[8]	高胜男, 张冉冉, 张羽曦, 高宁, 冯冰, 刘国强. 我国糖尿病神经病理性疼痛疾病负担及药物治疗进展[J]. 临床荟萃, 2024, 39(9): 842-846.
[9]	焦菲, 姚治平, 王兰桂. 中枢神经系统棘球幼病(包虫病)癫痫发作的危险因素[J]. 临床荟萃, 2024, 39(8): 712-715.
[10]	马一夫, 路鑫. 现代中药复方还脑益聪方治疗老年痴呆症作用机制的研究进展[J]. 临床荟萃, 2024, 39(8): 752-757.
[11]	朱萌然, 胡宵月, 苏芮, 杨旭旭, 漆平, 白云. 肝硬化凝血功能紊乱与出血、血栓形成的研究进展[J]. 临床荟萃, 2024, 39(7): 658-663.
[12]	陈诗雨, 罗专波. 肿瘤相关静脉血栓栓塞症研究进展[J]. 临床荟萃, 2024, 39(4): 363-369.
[13]	陈岚, 李叶琼, 冶秀鹏. 费城染色体阴性骨髓增殖性肿瘤患者血栓形成影响因素[J]. 临床荟萃, 2024, 39(4): 370-375.
[14]	李倩, 钟平. 帕金森病伴脑白质病变患者临床特征及危险因素分析[J]. 临床荟萃, 2024, 39(3): 222-226.
[15]	孙庆, 王海龙, 米庆, 乐暾, 牟华明. 外泌体在心力衰竭发生发展中的作用及临床价值[J]. 临床荟萃, 2024, 39(3): 259-263.